Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer

By sjmartinez • June 12, 2023

Ziyeh S, Wong L, Basho RK. Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer. Curr Oncol Rep. 2023 Jul;25(7):689-698. doi: 10.1007/s11912-023-01393-6. Epub 2023 Apr 1. PMID: 37004700.

Tags: AKT inhibition, CDK4/6 inhibition, CERANs, Endocrine therapy, Fellow, General Internal Medicine, Hematology/Oncology, HER2 negative breast cancer, Hormone receptor-positive breast cancer, Olive View DoM, PI3K inhibition, PIK3CA mutation, PROTACs, Publications, SARMs, SERCAs, SERDs, SERMs

Evaluation of the Reliability and Validity of the Retirement Knowledge Scale (RKS)

Blanco LR, Hays RD. Evaluation of the Reliability and Validity of the Retirement Knowledge Scale (RKS). J Retire. 2024 Fall;12(2):76-94. doi: 10.3905/jor.2024.1.164. Epub 2024 Oct[...]

Association of BRAF V600E allele frequency with clinicopathologic outcomes in papillary thyroid cancer

Schumm MA, Nikiforov YE, Nikiforova MN, Wald AI, Tseng CH, Smooke-Praw S, Wu JX, Yeh MW, Livhits MJ. Association of BRAF V600E allele frequency with[...]

Referrals and Black-White Coronary Heart Disease Treatment Disparities: A Qualitative Study of Primary Care Physician Perspectives

Qureshi N, Berry S, Damberg CL, Gibson B, Popescu I. Referrals and Black-White Coronary Heart Disease Treatment Disparities: A Qualitative Study of Primary Care Physician[...]